BIOMERICA INC Form PRE 14A: Preliminary proxy statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2025-10-09: Form PRE 14A; Period of report 2025-10-09; Description PRE 14A; Document formpre14a.htm.
- 2024-09-20: Form PRE 14A; Period of report 2024-12-13; Description Preliminary proxy statement; Document formpre14a.htm.
- 2002-09-25: Form PRE 14A; Period of report 2002-11-20; Description Preliminary proxy statement; Document biomerica_pre14a-2002.txt.
- 2001-09-21: Form PRE 14A; Period of report 2001-11-13; Description Preliminary proxy statement; Document biomerica_pre14a-2001.txt.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2025-10-09 | PRE 14A | 2025-10-09 | PRE 14A | formpre14a.htm |
| 2024-09-20 | PRE 14A | 2024-12-13 | Preliminary proxy statement | formpre14a.htm |
| 2002-09-25 | PRE 14A | 2002-11-20 | Preliminary proxy statement | biomerica_pre14a-2002.txt |
| 2001-09-21 | PRE 14A | 2001-11-13 | Preliminary proxy statement | biomerica_pre14a-2001.txt |
| 1999-09-14 | PRE 14A | 1999-10-25 | BIOMERICA, INC. |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |